Evidence map›Paper›PMID 41684015›Full record

ArticleInternational journal of molecular sciences2026

Tracking the Progress of Biocomposites Based on Poly(3-hydroxybutyrate) with Hypromellose Additives via Thermal Analysis, Mechanical Properties, and Biological Studies.

Karolina Maternia-Dudzik, Łukasz Ożóg, Zuzanna Bober, Rafał Oliwa, Mariusz Oleksy, Angelika Kamizela, Agnieszka Szyszkowska, Katarzyna Rafińska, Weronika Gonciarz, Kamil Gancarczyk and 1 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Karolina Maternia-DudzikLaboratory of Physical Chemistry and Biophysics, Centre for Innovative Research in Medical and Natural Sciences, Faculty of Medicine, University of Rzeszow, 35-959 Rzeszow, Poland.ORCID 0000-0002-7436-4929
Łukasz OżógLaboratory of Physical Chemistry and Biophysics, Centre for Innovative Research in Medical and Natural Sciences, Faculty of Medicine, University of Rzeszow, 35-959 Rzeszow, Poland.ORCID 0000-0003-4562-1639
Zuzanna BoberLaboratory of Physical Chemistry and Biophysics, Centre for Innovative Research in Medical and Natural Sciences, Faculty of Medicine, University of Rzeszow, 35-959 Rzeszow, Poland.ORCID 0000-0002-7035-0677
Rafał OliwaDepartment of Polymer Composites, Faculty of Chemistry, Rzeszow University of Technology, 35-959 Rzeszow, Poland.ORCID 0000-0003-1319-6199
Mariusz OleksyDepartment of Polymer Composites, Faculty of Chemistry, Rzeszow University of Technology, 35-959 Rzeszow, Poland.ORCID 0000-0001-5515-8575
Angelika KamizelaLaboratory of Physical Chemistry and Biophysics, Centre for Innovative Research in Medical and Natural Sciences, Faculty of Medicine, University of Rzeszow, 35-959 Rzeszow, Poland.ORCID 0000-0001-5565-2100
Agnieszka SzyszkowskaProvincial Hospital in Kielce, 25-736 Kielce, Poland.ORCID 0009-0003-2086-7832
Katarzyna RafińskaDepartment of Environmental Chemistry and Bioanalytics, Faculty of Chemistry, Nicolaus Copernicus University in Torun, 87-100 Torun, Poland.
Weronika GonciarzDepartment of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz, 90-237 Lodz, Poland.ORCID 0000-0002-5231-5341
Kamil GancarczykDepartment of Material Science, Faculty of Mechanical Engineering and Aeronautics, Rzeszow University of Technology, 35-959 Rzeszow, Poland.ORCID 0000-0002-5938-6636
Anna Czerniecka-KubickaLaboratory of Physical Chemistry and Biophysics, Centre for Innovative Research in Medical and Natural Sciences, Faculty of Medicine, University of Rzeszow, 35-959 Rzeszow, Poland.

Funding

Podkarpackie Innovation Center 36/UR/1/DG/PCI/2021.
6 · The paper itself

Abstract

Poly(3-hydroxybutyrate) (P3HB) was used to produce biocompatible composites with hypromellose as an additive. The study aimed to assess their biological and mechanical properties, as well as specific thermal parameters and phase content. Differential scanning calorimetry was applied to analyze the phase transitions of both biocomposites and the polymer matrix. Furthermore, the thermal parameters-encompassing both non-equilibrium and equilibrium states-of the biocomposites and unfilled P3HB were evaluated according to their thermal history. Using equilibrium parameters such as the heat of fusion for fully crystalline materials and the heat capacity change at the glass transition for fully amorphous composites, we estimated the degrees of crystallinity as well as the mobile and rigid amorphous fractions. Adding hypromellose to the P3HB matrix reduced crystallinity compared to the unfilled material. At the same time, an increase in the amorphous phase was observed. It was also discovered that the rigid amorphous fraction exists solely in biocomposites containing 2% by mass of filler. Thermogravimetric analysis showed that the thermal stability of all biocomposites surpasses that of unfilled P3HB. Adding an extra 1% filler by mass raises the degradation temperature by about 37 °C compared to unfilled P3HB. The immunosafety of the tested biocomposites, with very low or no endotoxin contamination, was confirmed in accordance with Food and Drug Administration and European Medicines Agency guidelines. The study clearly demonstrates the influence of the filler in the P3HB matrix on various structural, thermal, mechanical, and biological properties of the prepared biocomposites.

Indexed as

Biocompatible MaterialsHydroxybutyratesPolyestersAnimalsCalorimetry, Differential ScanningMaterials TestingPhase TransitionPolyhydroxybutyratesTemperatureThermogravimetryBiocompatible MaterialsHydroxybutyratespoly-beta-hydroxybutyratePolyestersPolyhydroxybutyratesbiocompatible materialsbiocompositehypromellosepoly(3-hydroxybutyrate)

Identifiers

PMID41684015
PMCPMC12898418

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.